Immunotherapy-induced autoimmune hypophysitis
Autoimmune hypophysitis is an immune-related adverse event of immune checkpoint inhibitors. In this article, we present the case of a 58-year-old female patient who presented to the emergency room with gradually worsening nonspecific symptoms of headache, nausea, vomiting and decreased oral intake o...
Saved in:
| Published in: | Journal of oncology pharmacy practice Vol. 25; no. 1; p. 217 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.01.2019
|
| Subjects: | |
| ISSN: | 1477-092X, 1477-092X |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Autoimmune hypophysitis is an immune-related adverse event of immune checkpoint inhibitors. In this article, we present the case of a 58-year-old female patient who presented to the emergency room with gradually worsening nonspecific symptoms of headache, nausea, vomiting and decreased oral intake of one week duration. The patient had been diagnosed with relapsed extensive stage small cell lung cancer. She was being treated with a combination of ipilimumab and nivolumab after progression on chemotherapy. Gadolinium-enhanced magnetic resonance imaging of head revealed pituitary enlargement up to 1.5 cm and pituitary stalk enlargement up to 4 mm consistent with hypophysitis. The patient was treated with corticosteroids resulting in rapid resolution of her symptoms. The objective of our report is to highlight this rare but important adverse event associated with checkpoint inhibitors, and discuss its clinical features, diagnostic work-up and treatment. |
|---|---|
| AbstractList | Autoimmune hypophysitis is an immune-related adverse event of immune checkpoint inhibitors. In this article, we present the case of a 58-year-old female patient who presented to the emergency room with gradually worsening nonspecific symptoms of headache, nausea, vomiting and decreased oral intake of one week duration. The patient had been diagnosed with relapsed extensive stage small cell lung cancer. She was being treated with a combination of ipilimumab and nivolumab after progression on chemotherapy. Gadolinium-enhanced magnetic resonance imaging of head revealed pituitary enlargement up to 1.5 cm and pituitary stalk enlargement up to 4 mm consistent with hypophysitis. The patient was treated with corticosteroids resulting in rapid resolution of her symptoms. The objective of our report is to highlight this rare but important adverse event associated with checkpoint inhibitors, and discuss its clinical features, diagnostic work-up and treatment. Autoimmune hypophysitis is an immune-related adverse event of immune checkpoint inhibitors. In this article, we present the case of a 58-year-old female patient who presented to the emergency room with gradually worsening nonspecific symptoms of headache, nausea, vomiting and decreased oral intake of one week duration. The patient had been diagnosed with relapsed extensive stage small cell lung cancer. She was being treated with a combination of ipilimumab and nivolumab after progression on chemotherapy. Gadolinium-enhanced magnetic resonance imaging of head revealed pituitary enlargement up to 1.5 cm and pituitary stalk enlargement up to 4 mm consistent with hypophysitis. The patient was treated with corticosteroids resulting in rapid resolution of her symptoms. The objective of our report is to highlight this rare but important adverse event associated with checkpoint inhibitors, and discuss its clinical features, diagnostic work-up and treatment.Autoimmune hypophysitis is an immune-related adverse event of immune checkpoint inhibitors. In this article, we present the case of a 58-year-old female patient who presented to the emergency room with gradually worsening nonspecific symptoms of headache, nausea, vomiting and decreased oral intake of one week duration. The patient had been diagnosed with relapsed extensive stage small cell lung cancer. She was being treated with a combination of ipilimumab and nivolumab after progression on chemotherapy. Gadolinium-enhanced magnetic resonance imaging of head revealed pituitary enlargement up to 1.5 cm and pituitary stalk enlargement up to 4 mm consistent with hypophysitis. The patient was treated with corticosteroids resulting in rapid resolution of her symptoms. The objective of our report is to highlight this rare but important adverse event associated with checkpoint inhibitors, and discuss its clinical features, diagnostic work-up and treatment. |
| Author | Pant, Manisha Valecha, Gautam Atallah, Jean P Ibrahim, Uroosa |
| Author_xml | – sequence: 1 givenname: Gautam orcidid: 0000-0002-2590-6402 surname: Valecha fullname: Valecha, Gautam organization: 1 Department of Medicine, 7601 Staten Island University Hospital , NY, USA – sequence: 2 givenname: Manisha surname: Pant fullname: Pant, Manisha organization: 1 Department of Medicine, 7601 Staten Island University Hospital , NY, USA – sequence: 3 givenname: Uroosa surname: Ibrahim fullname: Ibrahim, Uroosa organization: 2 Department of Hematology/Oncology, Staten Island University Hospital, NY, USA – sequence: 4 givenname: Jean P surname: Atallah fullname: Atallah, Jean P organization: 2 Department of Hematology/Oncology, Staten Island University Hospital, NY, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28825378$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj0tLxDAUhYOMOA_du5JZuokmN80kWcrgY2DAjYK7kia3NNKXTbPov7fiCK7OB-fjwFmTRdu1SMg1Z3ecK3XPmdJcSpgZFM_gjKx4phRlBj4W_3hJ1jF-Msa0An1BlqA1SKH0itBD06S2GyscbD_R0Prk0G9tGrvw0-C2mvqur6YYxhAvyXlp64hXp9yQ96fHt_0LPb4-H_YPR-rETo7UG-8MigJ5KZkDoQqNzHjjCgBbMs8KYXcCPJfGzi5ks4dSGOaVtsARNuT2d7cfuq-EccybEB3WtW2xSzHnRjAjskztZvXmpKaiQZ_3Q2jsMOV_F-EbRUVVZw |
| CitedBy_id | crossref_primary_10_1007_s40278_019_56416_6 crossref_primary_10_1177_1078155220910202 crossref_primary_10_1177_19714009221114444 crossref_primary_10_3166_afmu_2019_0170 crossref_primary_10_3390_cancers16101896 crossref_primary_10_1007_s11916_019_0740_x crossref_primary_10_1016_j_currproblcancer_2020_100644 crossref_primary_10_1186_s44201_023_00023_y crossref_primary_10_3390_cancers17030436 crossref_primary_10_1136_jim_2021_001806 crossref_primary_10_1016_j_ecl_2025_06_003 crossref_primary_10_3390_cancers17172805 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/1078155217727142 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1477-092X |
| ExternalDocumentID | 28825378 |
| Genre | Journal Article Case Reports |
| GroupedDBID | --- -TM .2E .2F .2G .2J .2N 01A 0R~ 18M 1~K 29L 31R 31S 31U 31X 31Y 31Z 36B 4.4 53G 54M 5GY 5VS 6PF 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8R4 8R5 AABMB AACKU AACMV AACTG AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAJQC AAKGS AANSI AAPEO AAQDB AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAWTL AAXOT AAYTG AAZBJ ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHKI ABHQH ABJNI ABKRH ABLUO ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABUWG ABVFX ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACIWK ACJER ACJTF ACLFY ACLHI ACLZU ACOFE ACOXC ACPRK ACROE ACRPL ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADDLC ADEIA ADMPF ADNBR ADNMO ADNON ADRRZ ADTBJ ADUKL ADVBO ADYCS ADZZY AECGH AECVZ AEDTQ AEKYL AEPTA AEQLS AERKM AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFRAH AFUIA AFWMB AGHKR AGKLV AGNHF AGPXR AGWFA AGWNL AHBZF AHDMH AHHFK AHMBA AIEWD AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AUVAJ AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKEYQ BKIIM BKSCU BMSDO BPACV BPHCQ BSEHC BVXVI BWJAD C45 CAG CBRKF CCPQU CDWPY CFDXU CGR COF CORYS CQQTX CS3 CUTAK CUY CVF DB0 DC- DC. DC0 DD- DD0 DE- DF. DF0 DO- DOPDO DV7 DV9 DWQXO D~Y EBS ECM EIF EJD EX3 F5P FEDTE FHBDP FYUFA GNUQQ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GUQSH H13 HF~ HMCUK HVGLF HZ~ J5H J8X K.F K.J M1P M2O M4V N9A NAPCQ NPM O9- OVD P.B P2P PADUT PHGZT PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SAUOL SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM TEORI UKHRP WOW ZONMY ZPPRI ZRKOI ZSSAH 7X8 AAPII ABIDT ABJZC ADEBD AJGYC AJHME AJVBE SASJQ |
| ID | FETCH-LOGICAL-c365t-d9dc9e3be1f50c237b8e09d9cb22af0d0b3a632d159ad9d241f5e5390d78a21e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 10 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000452337500025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-092X |
| IngestDate | Thu Oct 02 12:03:24 EDT 2025 Thu Apr 03 07:09:37 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | adverse events nivolumab autoimmune hypophysitis Immunotherapy ipilimumab |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c365t-d9dc9e3be1f50c237b8e09d9cb22af0d0b3a632d159ad9d241f5e5390d78a21e2 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0000-0002-2590-6402 |
| PMID | 28825378 |
| PQID | 1930934476 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1930934476 pubmed_primary_28825378 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-Jan 20190101 |
| PublicationDateYYYYMMDD | 2019-01-01 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-Jan |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Journal of oncology pharmacy practice |
| PublicationTitleAlternate | J Oncol Pharm Pract |
| PublicationYear | 2019 |
| SSID | ssj0008728 |
| Score | 2.184297 |
| Snippet | Autoimmune hypophysitis is an immune-related adverse event of immune checkpoint inhibitors. In this article, we present the case of a 58-year-old female... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 217 |
| SubjectTerms | Antineoplastic Agents, Immunological - adverse effects Autoimmune Hypophysitis - chemically induced Autoimmune Hypophysitis - diagnostic imaging Female Humans Immunotherapy - adverse effects Ipilimumab - adverse effects Middle Aged Nivolumab - adverse effects |
| Title | Immunotherapy-induced autoimmune hypophysitis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28825378 https://www.proquest.com/docview/1930934476 |
| Volume | 25 |
| WOSCitedRecordID | wos000452337500025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qRLz4Mb_mFxVkpwXTpGmSk4g49LDRw4TeRtokuEs73Sbsv_el7ehJELyUQj8oL7--_PJe3vshdC8jp03IM-zpPI64tFhZHWJmhMwjSpjlphKbEOOxTFOVNAG3RbOtcuMTK0dtytzHyB-AaMDiO4pE_Dj_xF41ymdXGwmNbdRhQGU8qkXadguXotJWDSMhMFE0bdOU4CyE9N3H4JyK0Au1_0Ywq4lmePjfTzxCBw3FDJ5qTByjLVt00d6oSaJ3UT-p21WvB8Gkrb5aDIJ-kLSNrNcnCL_54pGmRGuNYfUOODCBXi3Lmb9ig4_1vKxiI8vZ4hS9D18mz6-4kVfAOYv5EhtlcmVZZkPHSU6ZyKQlyqg8o1Q7YkjGdMwojKTScC9M9Y5bzhSBYdQ0tPQM7RRlYS9QoImzMXehA37gi12lcsaynDieMRHFcQ_dbSw2Bfj6nIQubLlaTFub9dB5bfbpvO6zMYX3UM6EvPzD01doH6iMqoMj16jj4Oe1N2g3_wYDfN1WuIDjOBn9AJlEwjI |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunotherapy-induced+autoimmune+hypophysitis&rft.jtitle=Journal+of+oncology+pharmacy+practice&rft.au=Valecha%2C+Gautam&rft.au=Pant%2C+Manisha&rft.au=Ibrahim%2C+Uroosa&rft.au=Atallah%2C+Jean+P&rft.date=2019-01-01&rft.issn=1477-092X&rft.eissn=1477-092X&rft.volume=25&rft.issue=1&rft.spage=217&rft_id=info:doi/10.1177%2F1078155217727142&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-092X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-092X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-092X&client=summon |